Abstract
In this neuropathology case report, we present findings from an individual with Down syndrome (DS) who remained cognitively stable despite Alzheimer’s disease (AD) neuropathology. Clinical assessments, fluid biomarkers, neuroimaging, and neuropathological examinations were conducted to characterize her condition. Notably, her ApoE genotype was E2/3, which is associated with a decreased risk of dementia. Neuroimaging revealed stable yet elevated amyloid profiles and moderately elevated tau levels, while neuropathology indicated intermediate AD neuropathologic change with Lewy body pathology and cerebrovascular pathology. Despite the presence of AD pathology, the participant demonstrated intact cognitive functioning, potentially attributed to factors such as genetic variations, cognitive resilience, and environmental enrichment. The findings suggest a dissociation between clinical symptoms and neuropathological changes, emphasizing the complexity of AD progression in DS. Further investigation into factors influencing cognitive resilience in individuals with DS, including comorbidities and social functioning, is warranted. Understanding the mechanisms underlying cognitive stability in DS could offer insights into resilience to AD neuropathology in people with DS and in the general population and inform future interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the NIH/NIA U19AG068054, P30AG066519, U01AG051412, RF1AG079519, P01AG025204, P01AG014449, and NIH/NICHD R01HD065160.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Committee for Oversight of Research and Clinical Training Involving Decedents of the University of Pittsburgh and the University of California, Irvine gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
List of abbreviations
- Aβ40
- amyloid beta 40
- Aβ42
- amyloid beta 42
- AD
- Alzheimer’s disease
- ApoE
- apolipoprotein E
- APP
- amyloid precursor protein
- BMI
- body mass index
- CAA
- cerebral amyloid angiopathy
- CERAD
- Consortium to Establish a Registry for Alzheimer’s disease
- CS
- cognitively stable
- CSF
- cerebrospinal fluid
- DLD
- Dementia Questionnaire for People with Learning Disabilities
- DS
- Down syndrome
- DSMSE
- Down Syndrome Mental Status Examination
- FBP
- florbetapir
- FSIQ
- full scale IQ
- GFAP
- glial fibrillary acidic protein
- KBIT-2
- Kaufman Brief Intelligence Test, 2nd Edition
- MCI
- mild cognitive impairment
- MRI
- magnetic resonance imaging
- NfL
- neurofilament light
- PET
- positron emission tomography pTau181: phosphorylated tau 181
- RADD-2
- Rapid Assessment for Developmental Disabilities, 2nd Edition
- ROI
- region of interest
- SUVR
- standardized uptake value ratio
- tTau
- total tau
- WAIS-R
- Wechsler Adult Intelligence Scale, Revised Edition
